Pharmaceutical Medicines

Product Description

We are engaged in offering 400 mg Tocilizumab Injection to our clients. Our range of all products is widely appreciated by our client

Product Description

Tocilizumab is mainly used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis and also reduces mortality in patients with severe COVID-19 prone to CRS and ARDS.s.

Product Specifications

Form

Liquid

Packaging Size

5 kg

Functions

Antioxidants

Usage/Application

Industrial

Grade Standard

Technical Grade

Material

Plastic

Categories

Adhesives

Solubility

Insoluble in water

Process

Hydrogenation Catalyst

Product Description

Product: Caluanie Muelear Oxidize ( Crude Caluanie 99% is generated from Muelear oxidize), Caluanie (Oxidative Partarization Thermostat, Heavy Water): This product is used for crushing and processing precious metals and semi precious stones. It is used for processing precious and semiprecious stones, crushing metals in the chemical industry.

Zepbound is prescribed for weight loss and long-term weight management in adults with either:

a body mass index (BMI) of 30 or higher (obesity)a BMI of 27 or higher (overweight) and a weight-related health condition, such as type 2 diabetes, high blood pressure, heart disease, high cholesterol, or obstructive sleep apneaZepbound is prescribed along with a reduced-calorie diet and increased exercise.

Zepbound helps you lose weight by reducing your appetite. The drug also slows down digestion, so after eating you feel fuller sooner and for longer. These effects help you consume fewer calories, which can help with weight loss and long-term weight management.

It's important to note that your doctor will likely not prescribe Zepbound if you:

take other medications containing tirzepatide (the active ingredient* in Zepbound), such as Mounjarotake similar glucagon-like peptide-1 medications, such as semaglutide (Ozempic, Wegovy) or liraglutide (Saxenda, Victoza)take any other weight loss products, including prescription drugs, over-the-counter medications, or herbal productshave had pancreatitis (inflammation of your pancreas) before

Product Description

Folotyn (pralatrexate injection) is an antineoplastic (anti-cancer) drug used to treat T-cell lymphoma that has spread throughout the body. Folotyn is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is based on overall response rate. Clinical benefit such as improvement in progression free survival or overall survival has not been demonstrated

Product Specifications

Packaging Size

2*250mg

Brand

faslodex 250mg

Composition

fulvestrant 250mg

Manufacturer

astrazenica

Prescription/Non prescription

Prescription

Form

Tablet

Product Brochure

download pdf

View Now

Product Description

Delivering Quality Medicines At Healtheir Life...we Are 

Directly Dealing Anticancer Injection/tablets/capsule At Good Rate With Quality...

Reliable & Affordable Medicine At Discounted Rates.

gamma butyrolactone gbl product specifications

brand

gbl

finish

polished

form

liquid

packaging size

1000ml

usage/application

cleaning

quantity per pack

1000ml

packaging type

bottle

foam

0%

sku code

uf76r68

minimum order quantity

10 piece

delivery time

5-7 working

product description

description by manufacturer

gbl wheel cleaner is one of the most efficient and fastest iron dust removal. with neutral ph and zero stimulating chemicals, it can be used to remove serious oxides on the car surface. it can be used safely on the surface of car paint, electroplated wheel ring and plastic parts. it has a strong effect of cleaning and discoloration for the brake dust and oxides on the surface of car paint.

product attributes

- brand name – gbl

- place of origin - turkey

- supply typein-stock items

- condition – new

- color – transparent

- purity - 99.9

- related keywords - gbl, stain remover, liquid solvent, research chemicals, sell pure gbl, buy gbl, car cleaner

Product Specifications

CAS No

151-50-8

Grade

Industrial Grade

Molecular Formula

KCN

Purity

99%

Usage/Application

Jewellery Electroplating

Physical Form

Crystall Powder

Molar Mass

65.12 g/mol

Boiling Point

1,625 DegreeC

Melting Point

634.5 DegreeC

Density

1.52 g/cm3

Minimum Order Quantity

10 GRAM

Product Description

RITLECITINIB treats alopecia areata, an autoimmune condition that causes hair loss. It works by slowing down an overactive immune system. RITLECITINIB treats alopecia areata, an autoimmune condition that causes hair loss. It works by slowing down an overactive immune system.

Product Description

Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.

The drug was developed at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE). It was then acquired by Miami-based company Ridgeback Biotherapeutics, who later partnered with Merck & Co. to develop the drug further.

Safety controversyIn April 2020, a whistleblower complaint by former Head of US Biomedical Advanced Research and Development Authority (BARDA) Rick Bright revealed concerns over providing funding for the further development of molnupiravir due to similar drugs having mutagenic (DNA damaging) properties.[3] A previous company, Pharmasset, that had investigated the drug's active ingredient had abandoned it. These claims were denied by George Painter, CEO of DRIVE, noting that toxicity studies on molnupiravir had been carried out and data provided to regulators in the US and UK, who permitted safety studies in humans to move forward in the spring of 2020. Also at this time, DRIVE and Ridgeback Biotherapeutics stated they planned future safety studies in 

Product Description

Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.

The drug was developed at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE). It was then acquired by Miami-based company Ridgeback Biotherapeutics, who later partnered with Merck & Co. to develop the drug further.

Safety controversyIn April 2020, a whistleblower complaint by former Head of US Biomedical Advanced Research and Development Authority (BARDA) Rick Bright revealed concerns over providing funding for the further development of molnupiravir due to similar drugs having mutagenic (DNA damaging) properties.[3] A previous company, Pharmasset, that had investigated the drug's active ingredient had abandoned it. These claims were denied by George Painter, CEO of DRIVE, noting that toxicity studies on molnupiravir had been carried out and data provided to regulators in the US and UK, who permitted safety studies in humans to move forward in the spring of 2020. Also at this time, DRIVE and Ridgeback Biotherapeutics stated they planned future safety studies in 

Product Description

Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.

The drug was developed at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE). It was then acquired by Miami-based company Ridgeback Biotherapeutics, who later partnered with Merck & Co. to develop the drug further.

Safety controversyIn April 2020, a whistleblower complaint by former Head of US Biomedical Advanced Research and Development Authority (BARDA) Rick Bright revealed concerns over providing funding for the further development of molnupiravir due to similar drugs having mutagenic (DNA damaging) properties.[3] A previous company, Pharmasset, that had investigated the drug's active ingredient had abandoned it. These claims were denied by George Painter, CEO of DRIVE, noting that toxicity studies on molnupiravir had been carried out and data provided to regulators in the US and UK, who permitted safety studies in humans to move forward in the spring of 2020. Also at this time, DRIVE and Ridgeback Biotherapeutics stated they planned future safety studies in 

Product Specifications

Strength

2.5 mg

Packaging Size

0.5 ml

Packaging Type

Injection

Manufacturer

Eli Lilly

Brand

Mounjaro

Manufacturer

Eli Lilly

Shelf Life

as per buyer

Prescription

No

Usage / Application

12month

Storage Conditions

cold

Minimum Order Quantity

3 Vial

Product Capacity

1000

Delivery Time

3-4 days

Packaging Details

sealed in box

Product Description

Mounjaro Tirzepatide Injection, 2.5 mgMounjaro Tirzepatide Injection, 2.5 mgMounjaro Tirzepatide Injection, 2.5 mgMounjaro Tirzepatide Injection, 2.5 mg

Mounjaro Tirzepatide Injection, 

Product Description

Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes.

Ozempic is a diabetes medicine used with diet and exercise to treat adults whose type 2 diabetes is not satisfactorily controlled. Ozempic can be used on its own in patients who cannot take metformin (another diabetes medicine). It can also be used as an 'add-on' to other diabetes medicines.

Ozempic Semaglutide Injection

Product Description

Ozempic (Semaglutide) is the brand name of the prescription medicine semaglutide, which is used to lower blood sugar levels in people with type 2 diabetes and help with weight loss.Ozempic (semaglutide) is a once-weekly injection used to improve blood sugar levels in adults with type 2 diabetes mellitus. Ozempic is also used to lower the risk of major cardiovascular events like stroke, heart attack or death, for adults with type 2 diabetes who also have heart disease.

Product Description

Ozempic (Semaglutide) is the brand name of the prescription medicine semaglutide, which is used to lower blood sugar levels in people with type 2 diabetes and help with weight loss.Ozempic (semaglutide) is a once-weekly injection used to improve blood sugar levels in adults with type 2 diabetes mellitus. Ozempic is also used to lower the risk of major cardiovascular events like stroke, heart attack or death, for adults with type 2 diabetes who also have heart disease.

Product Description

Rybelsus Tablet is a medicine used to lower blood sugar levels in adults with type 2 diabetes mellitus. It helps prevent serious complications of diabetes like kidney damage and blindness. Proper control of diabetes also helps lower your chances of a heart attack or a stroke.

Rybelsus Tablet belongs to the GLP-1 (glucagon-like peptide) group of diabetes medicines. It works by helping the body produce insulin and reducing appetite. It also helps reduce weight in some people. This medicine should be stored in a refrigerator until you need it but do not freeze it.

It is taken 30 minutes before the first meal of the day. The dose will depend on your condition and what other diabetes medicines you are taking. Do not stop taking this medicine without talking to your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications. Remember that it is only part of a treatment program that should also include a healthy diet and regular exercise. Your lifestyle plays a big part in controlling diabetes.

The most common side effects of this medicine include nausea, diarrhea, vomiting, decreased appetite, fatigue, and constipation. It can also lead to low blood sugar levels (hypoglycemia), especially if you are also taking other medicines, like insulin or sulfonylureas, for the treatment of diabetes. To prevent this, it is important to have regular meals, and always carry a fast-acting source of glucose, such as sugary candy or glucose candy, with you.

Before using Rybelsus Tablet, let your doctor know if you have any pancreas or stomach problems, severe dehydration (loss of body water), or diabetic ketoacidosis (a complication of diabetes characterized by too much acid and ketones in your blood). Pregnant or breastfeeding women should also consult their doctor before using this medicine. If you experience blurred vision, dizziness, or drowsiness due to extremely low or high blood sugar, do not drive, use machinery, or do any activity that requires alertness or clear vision until you are sure you can do them safely.

Product Description

Tocilizumab is mainly used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis and also reduces mortality in patients with severe COVID-19 prone to CRS and ARD

Product Description

We are engaged in offering 400 mg Tocilizumab Injection to our clients. Our range of all products is widely appreciated by our clients.S.

Wegovy Semaglutide Injection 0 25mg 0 5mg 1mg 1 7mg 2 4mg New Usa Worldwide Delivery ?

Product Description

Wegovy Injection (Semaglutide 2.4 mg/0.75 ml) is a prescription medication used to assist in weight management in adults with obesity or overweight conditions. It contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps regulate appetite and blood sugar levels.

Active Ingredient:

The active ingredient in Wegovy Injection is semaglutide, a GLP-1 receptor agonist that acts on specific receptors in the body to enhance feelings of fullness, reduce food intake, and improve glycemic control.

Usage:

Wegovy Injection is intended for adults with a body mass index (BMI) of 30 kg/m² or greater, or with a BMI of 27 kg/m² or greater along with at least one weight-related condition. It is administered as a subcutaneous injection once weekly.

Dosage:

The recommended dosage for Wegovy Injection is 2.4 mg once weekly. Your healthcare provider will provide specific instructions on how to administer the injection and may adjust the dosage based on your individual response.

International Brand Name:

Wegovy Injection may be known by the same name internationally or under different brand names specific to certain countries.

Delivery Process:

We offer worldwide shipping for Wegovy Injection, ensuring timely delivery within 2-10 days. All products are securely packaged according to international standards for safe transportation. Orders are dispatched within 48 hours of payment confirmation, and a unique tracking ID is provided to track the shipment.

Shipment Methods: EMS / Aramex / DHL / India Post / UPS / FedEx / Delhivery.

Ozempic Injection is a prescription medication used for managing type 2 diabetes. It is a valuable addition to the treatment options for type 2 diabetes as it effectively improves glucose control, reduces HbA1c levels, and promotes weight loss.

Active Ingredients : The active ingredient in Ozempic Injection is semaglutide, a synthetic form of the hormone GLP-1, which helps control blood sugar levels by increasing insulin secretion and reducing glucagon secretion.

Percocet is a combination opioid prescription drug. Opioid medications can either be formulated in a lab by scientists or made directly from the Opium plant.1 Opioids treat symptoms of pain with their relaxing properties. Generic Names for PercocetThe generic name for Percocet is oxycodone acetaminophen. The combination of oxycodone and acetaminophen, commonly known as Tylenol, forms the brand drug Percocet. Common Street Names for PercocetPercocet goes by different names outside of its branded name.2 Familiarizing oneself with the common street names helps prevent overusing the same medication, leading to an overdose. Common street names for Percocet include:3 Blue DynamiteNo Buffers512'sPercsBananasTiresRimsButtonsErcs. M-30sBlueBlueberries

Gardasil 9 is a vaccine approved by the U.S. Food and Drug Administration (FDA) for use in people 9 through 45 years of age to protect against the following diseases caused by certain types of human papillomavirus (HPV): Cervical cancer. Vulvar and vaginal cancers. Anal cancer.